Monocyte (THP-1) Response to Silver Nanoparticles Synthesized with Rumex hymenosepalus Root Extract
Authors:
- Francisco Javier Alvarez-CirerolFAFrancisco Javier Alvarez-Cirerol
- José Manuel Galván-MoroyoquiJGJosé Manuel Galván-Moroyoqui
- Ericka Rodríguez-LeónEREricka Rodríguez-León
- Carmen Candía-PlataCCCarmen Candía-Plata
- César Rodríguez-BeasCRCésar Rodríguez-Beas
- Luis Fernando López-SotoLLLuis Fernando López-Soto
- Blanca Esthela Rodríguez-VázquezBRBlanca Esthela Rodríguez-Vázquez
- José Bustos-ArriagaJosé Bustos-Arriaga
- Adriana Soto-GuzmánAdriana Soto-Guzmán
- Eduardo Larios-RodríguezELEduardo Larios-Rodríguez
- Juan M. Martínez-SotoJMJuan M. Martínez-Soto
- Aaron Martinez-HigueraAMAaron Martinez-Higuera
Open Access
- 2 January 2024
- journal article
- research article
- Published by MDPI AG in Nanomaterials
- Vol. 14 (1) , 106
Abstract
The study, synthesis, and application of nanomaterials in medicine have grown exponentially in recent years. An example of this is the understanding of how nanomaterials activate or regulate the immune system, particularly macrophages. In this work, nanoparticles were synthesized using Rumex hymenosepalus as a reducing agent (AgRhNPs). According to thermogravimetric analysis, the metal content of nanoparticles is 55.5% by weight. The size of the particles ranges from 5–26 nm, with an average of 11 nm, and they possess an fcc crystalline structure. The presence of extract molecules on the nanomaterial was confirmed by UV-Vis and FTIR. It was found by UPLC-qTOF that the most abundant compounds in Rh extract are flavonols, flavones, isoflavones, chalcones, and anthocyanidins. The viability and apoptosis of the THP-1 cell line were evaluated for AgRhNPs, commercial nanoparticles (AgCNPs), and Rh extract. The results indicate a minimal cytotoxic and apoptotic effect at a concentration of 12.5 μg/mL for both nanoparticles and 25 μg/mL for Rh extract. The interaction of the THP-1 cell line and treatments was used to evaluate the polarization of monocyte subsets in conjunction with an evaluation of CCR2, Tie-2, and Arg-1 expression. The AgRhNPs nanoparticles and Rh extract neither exhibited cytotoxicity in the THP-1 monocyte cell line. Additionally, the treatments mentioned above exhibited anti-inflammatory effects by maintaining the classical monocyte phenotype CD14++CD16, reducing pro-inflammatory interleukin IL-6 production, and increasing IL-4 production.Keywords
This publication has 93 references indexed in Scilit:
- Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseasesBiomarker Research, 2014
- Inducible Arginase 1 Deficiency in Mice Leads to Hyperargininemia and Altered Amino Acid MetabolismPLOS ONE, 2013
- Induction of Apoptosis by Costunolide in Bladder Cancer Cells is Mediated through ROS Generation and Mitochondrial DysfunctionMolecules, 2013
- Synthesis of monodisperse silver nanoparticles for ink-jet printed flexible electronicsNanotechnology, 2011
- Nomenclature of monocytes and dendritic cells in bloodBlood, 2010
- Recent developments in CCR2 antagonistsExpert Opinion on Therapeutic Patents, 2009
- Silver nanoparticles: Green synthesis and their antimicrobial activitiesAdvances in Colloid and Interface Science, 2009
- Antioxidants modulate the IL‐6 induced inhibition of negative acute‐phase protein secretion in HepG2 cellsCell Biochemistry and Function, 2007
- ARGINASE: A CRITICAL REGULATOR OF NITRIC OXIDE SYNTHESIS AND VASCULAR FUNCTIONClinical and Experimental Pharmacology and Physiology, 2007
- Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2Nature Immunology, 2006